COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets

18 March 2021 - EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people ...

Read more →

AstraZeneca ChAdOx1-S COVID-19

18 March 2021 - The TGA is closely reviewing reports of anaphylaxis after four cases were reported following the AstraZeneca ChAdOx1-S ...

Read more →

Europe’s vaccine suspension may be driven as much by politics as science

16 March 2021 - Once it became clear Germany was pausing, the pressure mounted on other governments to hold off as ...

Read more →

PHARMAC’s drug switch

17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...

Read more →

AstraZeneca vaccine fears may be more deadly than any side effect

16 March 2021 - In Europe, vaccination against COVID-19 is off to a worryingly slow start. Just 11 doses for every ...

Read more →

ATAGI statement in response to European decisions about the AstraZeneca vaccine

16 March 2021 - ATAGI notes the suspension of the AstraZeneca vaccine program in several European countries due to reports ...

Read more →

Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues

16 March 2021 - EMA’s safety committee (PRAC) made further progress today in its detailed evaluation of cases of blood clots, ...

Read more →

Doctors complain of ‘gag’ over AstraZeneca vaccine

16 March 2021 - High-profile doctors have complained they are being gagged from speaking out about their concerns on the ...

Read more →

Facebook to label all posts about coronavirus vaccines

15 March 2021 - Facebook, which has been criticised by politicians and researchers for allowing vaccine misinformation to spread on ...

Read more →

Multiple countries pause AstraZeneca vaccine use

16 March 2021 - Germany, France and Italy are the latest countries to have suspended the AstraZeneca vaccine over blood clotting ...

Read more →

EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events

15 March 2021 - Several authorities responsible for national vaccine campaigns in EU countries have temporarily paused vaccination with COVID-19 Vaccine ...

Read more →

COVID-19 vaccines - safety and effectiveness in older adults

10 March 2021 - Data on real-world use of COVID-19 vaccines approved in Australia provides reassurance about their safety in ...

Read more →

COVID-19 vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks

11 March 2021 - The EMA is aware that the Danish Health Authority has paused its vaccination campaign with COVID-19 ...

Read more →

Women report worse side effects after a COVID-19 vaccine

8 March 2021 - Men and women tend to respond differently to many kinds of vaccines. That’s probably because of a ...

Read more →

PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist

4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...

Read more →